Form 4: MariMed Director Edward Gildea Exercises 75k RSU Grant

Director Edward Gildea acquired 75,000 shares of MariMed Inc. common stock through the vesting and conversion of restricted stock units.

Summary

• Director Edward Gildea exercised 75,000 restricted stock units (RSUs) on June 12, 2026.
• The RSUs converted into common stock on a one-for-one basis at a price of $0 per share.
• Following the transaction, the director holds a total of 980,208 shares of MariMed Inc. common stock.
• The transaction represents the final vesting of the RSU grant awarded on June 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the routine fulfillment of a previously granted equity compensation package.

Positives

• Director maintains a significant equity stake of 980,208 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of equity compensation vesting for a corporate director, which is standard practice in the cannabis and broader public equity sectors.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices regarding the vesting of director equity compensation.
• The one-for-one conversion of RSUs is consistent with typical equity incentive plan structures for U.S. publicly traded companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a pre-planned equity compensation event.

Next Steps

• No further actions or milestones mentioned.

Key Dates

Keywords

MariMed, MRMD, Form 4, Insider Trading, Equity Compensation, Director Ownership